ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
Researchers at the University of California, Riverside, have developed a nanopore-based diagnostic tool capable of detecting illnesses more quickly and accurately by analyzing signals from individual ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...
UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual ...
In this webinar, we will focus on the relevance of modifications, particularly DNA methylation at the fifth position of cytosine (5mC), in studying disease mechanisms in humans. We will present ...
Infectious disease poses a threat to human health and is becoming more dangerous with increasing urbanization, population growth, and climate change. Fortunately, genomic sequencing technologies have ...
Chief Financial Officer Nick Keher outlined the company’s progress in expanding beyond its historically research-led revenue base, highlighting rapid growth in clinical and applied industrial end ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results